Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies

Detalles Bibliográficos
Autores principales: Taenaka, Ryutaro, Obara, Teppei, Kohno, Kentaro, Aoki, Kenichi, Ogawa, Ryosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989258/
https://www.ncbi.nlm.nih.gov/pubmed/35391563
http://dx.doi.org/10.1007/s00277-022-04833-8
_version_ 1784683129383944192
author Taenaka, Ryutaro
Obara, Teppei
Kohno, Kentaro
Aoki, Kenichi
Ogawa, Ryosuke
author_facet Taenaka, Ryutaro
Obara, Teppei
Kohno, Kentaro
Aoki, Kenichi
Ogawa, Ryosuke
author_sort Taenaka, Ryutaro
collection PubMed
description
format Online
Article
Text
id pubmed-8989258
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-89892582022-04-11 Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies Taenaka, Ryutaro Obara, Teppei Kohno, Kentaro Aoki, Kenichi Ogawa, Ryosuke Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2022-04-07 2022 /pmc/articles/PMC8989258/ /pubmed/35391563 http://dx.doi.org/10.1007/s00277-022-04833-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Taenaka, Ryutaro
Obara, Teppei
Kohno, Kentaro
Aoki, Kenichi
Ogawa, Ryosuke
Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies
title Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies
title_full Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies
title_fullStr Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies
title_full_unstemmed Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies
title_short Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies
title_sort infections with the sars-cov-2 omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989258/
https://www.ncbi.nlm.nih.gov/pubmed/35391563
http://dx.doi.org/10.1007/s00277-022-04833-8
work_keys_str_mv AT taenakaryutaro infectionswiththesarscov2omicronvariantshowasimilaroutcomeasinfectionswiththepreviousvariantsinpatientswithhematologicmalignancies
AT obarateppei infectionswiththesarscov2omicronvariantshowasimilaroutcomeasinfectionswiththepreviousvariantsinpatientswithhematologicmalignancies
AT kohnokentaro infectionswiththesarscov2omicronvariantshowasimilaroutcomeasinfectionswiththepreviousvariantsinpatientswithhematologicmalignancies
AT aokikenichi infectionswiththesarscov2omicronvariantshowasimilaroutcomeasinfectionswiththepreviousvariantsinpatientswithhematologicmalignancies
AT ogawaryosuke infectionswiththesarscov2omicronvariantshowasimilaroutcomeasinfectionswiththepreviousvariantsinpatientswithhematologicmalignancies

Ejemplares similares